Invitrogen and Applied Biosystems this week named George Adam, Arnold Levine, and William Longfield to the board of the company that will be formed by their merger, Life Technologies.
The three are currently members of ABI’s board. Adam is chairman of Recondo Technology, Levine is a professor at the Institute for Advanced Study, and Longfield is the retired chairman and CEO of CR Baird.
Sigma-Aldrich last week announced a series of changes to management including the appointment of Rakesh Sachdev as vice president and CFO, effective Nov. 17. He replaces Mike Hogan as CFO who is retiring.
Sachdev was previously at ArvinMeritor, most recently as senior vice president and president Asia Pacific. He also served as CFO of a Cummins business unit.
In addition, Sigma-Aldrich said that Karen Miller is becoming vice president of strategy and corporate development. She has been controller. In her new position, she will identify growth opportunities through new ventures, partnerships, and alliances. She joined the company in 1997. Prior to that, she held various financial positions at Allergan and KPMG.
Also, Kevin Krosley will assume the role of vice president-New Ventures Group. He had been vice president of process improvement; Dave Julien moves from being president of research specialties to the newly created position of president-Supply Chain; Frank Wicks, currently president-SAFC, is becoming president of research specialties and research essentials; Gilles Cottier is moving from president of research essentials to become president-SAFC; Carl Turza, the company’s CIO, will take on added responsibilities for Internet-based initiatives to accelerate new e-commerce opportunities.